How Will the Upcoming Fed Meeting Impact the Stock Market?

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – The S&P 500 (SPY) has bounced back with a vengeance from its oversold state. Yet, there’s been little change in terms of the market’s overall tenor. From a top-down perspective, the indices continue grinding higher with any dip leading to higher highs. From a bottom-up viewpoint, the situation is less clear and favorable for bulls. There’s still a lack of follow-through on breakouts or strong earnings report. The upcoming Jackson Hole Fed meeting on Friday could also provide some clarity on the Fed’s path and timetable in terms of tapering. In this week’s commentary, I will provide a deeper look at the market from both vantage points and discuss our current portfolio strategy. Read on below to find out more….

(Please enjoy this updated version of my weekly commentary published August 25, 2021 from the POWR Growth newsletter).

The one-month, hourly chart shows that the S&P 500 is up 3% over the last week and now at new, all-time highs.

Unlike previous rallies, we are even seeing increased participation from small-cap stocks:

From Thursday’s low, the Russell 2000 is up 5%. However, this index is not at new highs and remains well below these levels as indicated by its six-month, daily chart:

In fact, it’s essentially been in a sideways range since February trading between 210 and 230.

And throughout this range – overbought readings have been met with selling, while oversold readings are met with furious buying.

This divergent state of affairs encapsulates the current market environment – the S&P 500 is in a grinding rally higher, while small and mid-cap stocks are locked into this excruciating range.

It’s quite remarkable that nothing has really changed this circumstance despite the plethora of news and events over the past six months such as the spike in coronavirus cases due to the Delta variant, the Fed inching towards a taper, 2 consecutive quarters of strong earnings results, and the likely passage of a $1+ trillion infrastructure bill and $3.5 trillion budget.

We’ve adapted to this situation by being a bit nimbler and more active in trading our small and mid-cap stocks while also retaining exposure to large cap stocks that will benefit from the drop in interest rates.

Speaking of Rates….

Let’s take a look at the 10-year, monthly chart of the 10-year yield:

As we can see, the S&P 500 can keep chugging higher regardless of what rates are doing. However, the trend in rates certainly do impact the type and composition of the rally.

For example, the 10-year dropped from above 3% to below 2% in 2019. During this time, cyclical stocks were in a bear market despite the S&P 500 gaining more than 20%.

Currently, the 10Y yield has dropped from 1.75% to 1.34%. This drop has correlated with underperformance in more economically sensitive parts of the market like housing, energy, and materials. This has created pessimism around the recovery and even led to increased chatter about the possibility that growth will drastically decelerate in the coming months.

We actually have a useful analogue in terms of what we went through from 2016 to 2018 which was the last bull market in rates.

In the early part of 2016, the market and rates dropped amid fears of a double-dip recession. While the market bottomed in February, rates made a lower low and bottomed soon following the Brexit vote which caught markets offsides.

From there, markets blasted higher with cyclicals leading for the rest of 2016. Then, there was profit-taking for much of 2017 until rates bottomed and once again started moving higher. During this time, small-caps and cyclicals underperformed, while the S&P 500 grinded higher. We had the same circumstance of earnings growth and low rates as we do today.

I believe that time period is quite similar to today in terms of earnings growth, low rates, and a powerful economic recovery. We are currently in the digestion phase which requires some patience, but we know that eventually it will resolve higher, and the big gains will be found in preparing for this outcome.

What To Do Next?

The POWR Growth portfolio was launched in early April and is off to a fantastic start.

What is the secret to success?

The portfolio gets most of its fresh picks from the Top 10 Growth Stocks strategy which has stellar +46.42% annual returns.

If you would like to see the current portfolio of growth stocks, and be alerted to our next timely trades, then consider starting a 30 day trial by clicking the link below.

About POWR Growth newsletter & 30 Day Trial

All the Best!

Jaimini Desai
Chief Growth Strategist, StockNews
Editor, POWR Growth Newsletter

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


SPY shares were trading at $446.36 per share on Thursday afternoon, down $2.55 (-0.57%). Year-to-date, SPY has gained 20.17%, versus a % rise in the benchmark S&P 500 index during the same period.


About the Author: Jaimini Desai


Jaimini Desai has been a financial writer and reporter for nearly a decade. His goal is to help readers identify risks and opportunities in the markets. He is the Chief Growth Strategist for StockNews.com and the editor of the POWR Growth and POWR Stocks Under $10 newsletters. Learn more about Jaimini’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating
.INXGet RatingGet RatingGet Rating
DIAGet RatingGet RatingGet Rating
IWMGet RatingGet RatingGet Rating
QQQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Expert Predicts 3-6 Months of Pain

2 important market developments are leading market expert Steve Reitmeister to predict 3 to 6 months of painful market conditions pushing the S&P 500 (SPY) lower. Read on for the full story...

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more...

3 Tech Stocks Analysts Say Are "Strong Buys" for 2025

The technology industry is well-positioned for significant growth thanks to the rapid advancements in emerging technologies and the digitization of business operations. Amid this backdrop, fundamentally solid tech stocks Adobe (ADBE), Leidos Holdings (LDOS), and DocuSign (DOCU) could be strong buys for 2025. Continue reading...

3 Tech Stocks Under $20 With Breakout Potential

The tech sector is the core of innovation, from transforming industries to powering economic progress. Amid this backdrop, investors could consider buying sound under $20 tech stocks Vimeo (VMEO), PubMatic (PUBM), and Eventbrite (EB). Keep reading…

How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News